Inside informationEnglish
Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 17/10/2025, 13:05
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 113659_20251017